Abbott has entered worldwide licensing agreement with Johnson & Johnson
for a large portfolio of intellectual property for developing and commercializing
rapid exchange (RX) delivery systems and related drug-eluting stents and interventional
products. According to the company release, the agreement will provide Abbott
with access to patents that enhance the company's ability to bring to market
an RX catheter delivery system.